Senator Tillis’ Patent Eligibility Reform Proposal: A Biopharma Perspective

By Kevin E. Noonan — Senator Thom Tillis (R-NC) introduced S. 4734, entitled "A Bill to amend Title 35, U.S. Code, to address matters relating to patent subject matter eligibility, and for other purposes" last night, as was discussed in an earlier Patent Docs post (see "Senator Tillis Proposes Patent Eligibility Reform (Again)"). Even a cursory read of the bill reveals that portions of it have been specifically crafted to address issues that have arisen in the inferior courts’ applications of the Supreme Court’s recent subject matter eligibility jurisprudence (particularly, and chronologically, Mayo Collaborative Services v. Prometheus Laboratories, Inc., Association…

Want to view the entire article? Click here: Senator Tillis’ Patent Eligibility Reform Proposal: A Biopharma Perspective

The article was originally posted on Patent Docs.
Each article is copyrighted to its original authors. We do not own any rights to the news or the images used. Whilst every care is taken to ensure that the news posts published are accurate, we cannot guarantee the authenticity of the news article on every occasion. There’s no copyright infringement intended. The news is for informational purposes only and does not provide legal advice.